Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohort

Gynecologic Oncology

Volumn 105, Issue 2, 2007, Pages 365-372

  Mom, C H ^a   Engelen, M J A ^a   Willemse, P H B ^a   Gietema, J A ^a   ten Hoor, K A ^a   de Vries, E G E ^a   van der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Granulosa cell tumor; Inhibin A; Inhibin B; Sex cord stromal tumor; Tumor marker

Indexed keywords

INHIBIN A; INHIBIN B;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GRANULOSA CELL TUMOR; HUMAN; MALE; OVARY TUMOR; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REMISSION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRANULOSA CELL TUMOR; HUMANS; INHIBINS; INTRAOPERATIVE PERIOD; MIDDLE AGED; OVARIAN NEOPLASMS; RADIOTHERAPY, ADJUVANT; UTERINE CERVICAL DYSPLASIA;

EID: 34247097444     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.12.034     Document Type: Article

References (35)

1. Aboud E. A review of granulosa cell tumours and thecomas of the ovary. Arch. Gynecol. Obstet. 259 (1997) 161-165
2. Merras-Salmio L., Vettenranta K., Mottonen M., and Heikinheimo M. Ovarian granulosa cell tumors in childhood. Pediatr. Hematol. Oncol. 19 (2002) 145-156
3. Young R.H., Dickersin G.R., and Scully R.E. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am. J. Surg. Pathol. 8 (1984) 575-596
4. Kalfa N., Ecochard A., Patte C., et al. Activating mutations of the stimulatory g protein in juvenile ovarian granulosa cell tumors: a new prognostic factor?. J. Clin. Endocrinol. Metab. 91 (2006) 1842-1847
5. Evans A.T., Gaffey T.A., Malkasian G.D., and Annegers J.F. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet. Gynecol. 55 (1980) 231-238
6. Hines J.F., Khalifa M.A., Moore J.L., Fine K.P., Lage J.M., and Barnes W.A. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol. Oncol. 60 (1996) 484-488
7. Lauszus F.F., Petersen A.C., Greisen J., and Jakobsen A. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease. Gynecol. Oncol. 81 (2001) 456-460
8. Malmström H., Högberg T., Risberg B., and Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol. Oncol. 52 (1994) 50-55
9. Crew K.D., Cohen M.H., Smith D.H., Tiersten A.D., Feirt N.M., and Hershman D.L. Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature. Gynecol. Oncol. 96 (2005) 235-240
10. Schumer S.T., and Cannistra S.A. Granulosa cell tumor of the ovary. J. Clin. Oncol. 21 (2003) 1180-1189
11. Pankratz E., Boyes D.A., White G.W., Galliford B.W., Fairey R.N., and Benedet J.L. Granulosa cell tumors. A clinical review of 61 cases. Obstet. Gynecol. 52 (1978) 718-723
12. Savage P., Constenla D., Fisher C., et al. Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin. Oncol. 10 (1998) 242-245
13. Lappöhn R.E., Burger H.G., Bouma J., Bangah M., Krans M., and de Bruijn H.W. Inhibin as a marker for granulosa-cell tumors. N. Engl. J. Med. 321 (1989) 790-793
14. Cooke I., O'Brien M., Charnock F.M., Groome N., and Ganesan T.S. Inhibin as a marker for ovarian cancer. Br. J. Cancer 71 (1995) 1046-1050
15. Healy D.L., Burger H.G., Mamers P., et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N. Engl. J. Med. 329 (1993) 1539-1542
16. Jobling T., Mamers P., Healy D.L., et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol. Oncol. 55 (1994) 285-289
17. Petraglia F., Luisi S., Pautier P., et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J. Clin. Endocrinol. Metab. 83 (1998) 1029-1032
18. Groome N.P., and Evans L.W. Does measurement of inhibin have a clinical role?. Ann. Clin. Biochem. 37 (2000) 419-431
19. Robertson D.M., Burger H.G., and Fuller P.J. Inhibin/activin and ovarian cancer. Endocr. Relat. Cancer 11 (2004) 35-49
20. Groome N.P., Illingworth P.J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 81 (1996) 1401-1405
21. Robertson D.M., Cahir N., Findlay J.K., Burger H.G., and Groome N. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J. Clin. Endocrinol. Metab. 82 (1997) 889-896
22. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., and Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 81 (1996) 2742-2745
23. Sehested A., Juul A.A., Andersson A.M., et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J. Clin. Endocrinol. Metab. 85 (2000) 1634-1640
24. Burger H.G., Cahir N., Robertson D.M., et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin. Endocrinol. 48 (1998) 809-813
25. Cronjé H.S., Niemand I., Bam R.H., and Woodruff J.D. Review of the granulosa-theca cell tumors from the Emil Novak Ovarian Tumor Registry. Am. J. Obstet. Gynecol. 180 (1999) 323-327
26. Pautier P., Lhommé C., Culine S., et al. Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int. J. Gynecol. Cancer 7 (1997) 58-65
27. East N., Alobaid A., Goffin F., Ouallouche K., and Gauthier P. Granulosa cell tumour: a recurrence 40 years after initial diagnosis. J. Obstet. Gynaecol. Can. 27 (2005) 363-364
28. Boggess J.F., Soules M.R., Goff B.A., Greer B.E., Cain J.M., and Tamimi H.K. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol. Oncol. 64 (1997) 64-69
29. Homesley H.D., Bundy B.N., Hurteau J.A., and Roth L.M. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol. Oncol. 72 (1999) 131-137
30. Rey R.A., Lhommé C., Marcillac I., et al. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am. J. Obstet. Gynecol. 174 (1996) 958-965
31. Gustafson M.L., Lee M.M., Scully R.E., et al. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N. Engl. J. Med. 326 (1992) 466-471
32. Lane A.H., Lee M.M., Fuller A.-F.J., Kehas D.J., Donahoe P.K., and MacLaughlin D.T. Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol. Oncol. 73 (1999) 51-55
33. Vihko K.K., Blauer M., Puistola U., and Tuohimaa P. Activin B in patients with granulosa cell tumors: serum levels in comparison to inhibin. Acta Obstet. Gynecol. Scand. 82 (2003) 570-574
34. Muttukrishna S., Fowler P.A., George L., Groome N.P., and Knight P.G. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 81 (1996) 3328-3334
35. Robertson D.M., Stephenson T., Pruysers E., et al. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. J. Clin. Endocrinol. Metab. 87 (2002) 816-824